Charles River Laboratories International Future Growth
Future criteria checks 2/6
Charles River Laboratories International is forecast to grow earnings and revenue by 13.6% and 5.9% per annum respectively. EPS is expected to grow by 13.2% per annum. Return on equity is forecast to be 14.4% in 3 years.
Key information
13.6%
Earnings growth rate
13.2%
EPS growth rate
Life Sciences earnings growth | 0% |
Revenue growth rate | 5.9% |
Future return on equity | 14.4% |
Analyst coverage | Good |
Last updated | 13 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 4,866 | 609 | 641 | 985 | 9 |
12/31/2025 | 4,529 | 513 | 573 | 878 | 14 |
12/31/2024 | 4,221 | 406 | 445 | 733 | 14 |
3/30/2024 | 4,112 | 444 | 414 | 704 | N/A |
12/30/2023 | 4,129 | 475 | 365 | 684 | N/A |
9/30/2023 | 4,216 | 475 | 368 | 698 | N/A |
7/1/2023 | 4,178 | 484 | 289 | 625 | N/A |
4/1/2023 | 4,092 | 496 | 275 | 626 | N/A |
12/31/2022 | 3,976 | 486 | 295 | 620 | N/A |
9/24/2022 | 3,781 | 436 | 280 | 614 | N/A |
6/25/2022 | 3,688 | 443 | 338 | 656 | N/A |
3/26/2022 | 3,630 | 422 | 412 | 693 | N/A |
12/25/2021 | 3,540 | 391 | 532 | 761 | N/A |
9/25/2021 | 3,426 | 397 | 452 | 670 | N/A |
6/26/2021 | 3,273 | 396 | 484 | 672 | N/A |
3/27/2021 | 3,041 | 375 | 479 | 648 | N/A |
12/26/2020 | 2,924 | 364 | 380 | 547 | N/A |
9/26/2020 | 2,824 | 301 | 446 | 589 | N/A |
6/27/2020 | 2,749 | 271 | 416 | 567 | N/A |
3/28/2020 | 2,724 | 248 | 385 | 535 | N/A |
12/28/2019 | 2,621 | 252 | 340 | 481 | N/A |
9/28/2019 | 2,532 | 231 | 295 | 440 | N/A |
6/29/2019 | 2,449 | 219 | 269 | 402 | N/A |
3/30/2019 | 2,377 | 227 | 264 | 393 | N/A |
12/29/2018 | 2,266 | 225 | 297 | 437 | N/A |
9/29/2018 | 2,143 | 135 | 321 | 421 | N/A |
6/30/2018 | 2,022 | 128 | 264 | 363 | N/A |
3/31/2018 | 1,906 | 129 | 248 | 342 | N/A |
12/30/2017 | 1,858 | 123 | N/A | 316 | N/A |
9/30/2017 | 1,846 | 198 | N/A | 310 | N/A |
7/1/2017 | 1,807 | 183 | N/A | 323 | N/A |
4/1/2017 | 1,772 | 164 | N/A | 303 | N/A |
12/31/2016 | 1,681 | 154 | N/A | 315 | N/A |
9/24/2016 | 1,568 | 143 | N/A | 299 | N/A |
6/25/2016 | 1,492 | 143 | N/A | 315 | N/A |
3/26/2016 | 1,398 | 156 | N/A | 321 | N/A |
12/26/2015 | 1,363 | 150 | N/A | 305 | N/A |
9/26/2015 | 1,339 | 146 | N/A | 284 | N/A |
6/27/2015 | 1,317 | 140 | N/A | 263 | N/A |
3/28/2015 | 1,319 | 127 | N/A | 234 | N/A |
12/27/2014 | 1,298 | 128 | N/A | 251 | N/A |
9/27/2014 | 1,257 | 120 | N/A | 214 | N/A |
6/28/2014 | 1,222 | 119 | N/A | 214 | N/A |
3/29/2014 | 1,174 | 111 | N/A | 205 | N/A |
12/28/2013 | 1,166 | 104 | N/A | 207 | N/A |
9/28/2013 | 1,156 | 108 | N/A | 210 | N/A |
6/29/2013 | 1,143 | 99 | N/A | 203 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRL *'s forecast earnings growth (13.6% per year) is above the savings rate (7.8%).
Earnings vs Market: CRL *'s earnings (13.6% per year) are forecast to grow faster than the MX market (11.3% per year).
High Growth Earnings: CRL *'s earnings are forecast to grow, but not significantly.
Revenue vs Market: CRL *'s revenue (5.9% per year) is forecast to grow slower than the MX market (7.1% per year).
High Growth Revenue: CRL *'s revenue (5.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CRL *'s Return on Equity is forecast to be low in 3 years time (14.4%).